|
Recurrence free survival
| | |
Overall survival
| | |
---|
| |
HR (95% CI)
| |
p-value
| |
HR (95% CI)
| |
p-value
|
Cohort I
| | | | | | | | |
| | |
Univariate
| | | |
Univariate
| |
low
|
(n = 115, nevent = 85)
|
1.00
| | |
(n = 115, nevent = 54)
|
1.00
| | |
high
|
(n = 142, nevent = 89)
|
0.64 (0.47-0.86)
| |
0.003
|
(n = 139, nevent = 50)
|
0.64 (0.44-0.95)
| |
0.024
|
| | |
Multivariate
| | | |
Multivariate
| |
low
|
(n = 103, nevent = 77)
|
1.00
| | |
(n = 103, nevent = 51)
|
1.00
| | |
high
|
(n = 119, nevent = 71)
|
0.61 (0.44-0.84)
| |
0.003
|
(n = 117, nevent = 50)
|
0.62 (0.41-0.95)
| |
0.028
|
Cohort II
| | | | | | | | |
| | | | | | |
Univariate
| |
negative
|
x
|
x
|
x
|
x
|
(n = 74, nevent = 33)
|
1.00
| | |
positive
|
x
|
x
|
x
|
x
|
(n = 77, nevent = 44)
|
0.53 (0.35-0.79)
| |
0.002
|
| | | | | | |
Multivariate
| |
negative
|
x
|
x
|
x
|
x
|
(n = 68, nevent = 29)
|
1.00
| | |
positive
|
x
|
x
|
x
|
x
|
(n = 71, nevent = 42)
|
0.61 (0.40-0.92)
| |
0.017
|
- Multivariate analysis included adjustment for age (continuous) stage (I-II vs III-IV), grade (I-II vs III) and residual disease (none vs any, only available for Cohort I).